Search

Search Constraints

You searched for: Author/Creator Dymond, Mike

Search Results

1. OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. (May 2023)